Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Alvexo - Opportunities in Vaccine Pharmaceuticals
Thank you for signing up for the webinar.
20 minutes before the session starts, a 'Start Webinar' button will appear on this page. Click the button to access the webinar.
Never miss a session by adding a reminder to your calendar.
Add to Calendar
Webinar has finished
Registered Users: 141
- Forex
- Cryptocurrency
- CFD
- Technical Analysis
- Beginners
- Intermediate
Add to Calendar
Final Step: Sponsor Registration
This free webinar is sponsored by %BROKER_NAME%. Please complete the form below in order to finalize your webinar registration.
The development of vaccines to combat SARS Covid-2, the virus that causes Covid-19 presents some tremendous opportunities for profit for traders. Beyond the near miraculous development of so many approved vaccines by various pharma partnerships, the new technology of MRNA medicines has massive long-term potential. Join your host Seth Julian for the Alvexo trade outlook.
Seth Julian:
Mr. Julian is a native Bostonian who has been trading for 5 decades. He started his professional career on Wall Street in the early 80’s at Bankers Trust Company. Having held trader and broker positions at several international finance houses, he is currently Chief Global Strategist at Alvexo. Seth is an E.U. certified and registered securities dealer. He holds a degree in Political Economy from Columbia University, an advanced degree in International Trade and Economics from the University of Chicago and an MBA from Northeastern University.
- Which firms are in play today
- What other firms benefit from the Covid-19 vaccine breakthroughs
- Why is MRNA such a revolution in pharmacology
- Opportunities beyond pharma resulting from the MRNA revolution
Seth Julian:
Mr. Julian is a native Bostonian who has been trading for 5 decades. He started his professional career on Wall Street in the early 80’s at Bankers Trust Company. Having held trader and broker positions at several international finance houses, he is currently Chief Global Strategist at Alvexo. Seth is an E.U. certified and registered securities dealer. He holds a degree in Political Economy from Columbia University, an advanced degree in International Trade and Economics from the University of Chicago and an MBA from Northeastern University.